ArticleJournal of clinical apheresis2026
Association Between Specialist Distribution and Regional Variation in Plasmapheresis Use in Japan: A Population-Level Cross-Sectional Study.
Article in Journal of clinical apheresis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Plasmapheresis is widely used in Japan; however, regional variation in its use and its association with specialist distribution remain unclear. We conducted a cross-sectional study using the 9th National Database Open Data (fiscal year 2022) to assess regional variation in plasmapheresis use and examined its association with the distribution of nephrologists, dialysis specialists, and apheresis specialists. Plasmapheresis use was identified using the relevant receipt code, and age- and sex-adjusted standardized claim ratios (SCRs) were calculated. Plasmapheresis use differed 6.5-fold across regions, with SCRs ranging from 34.0 to 222.4. Multivariable-adjusted negative binomial regression models showed that each additional board-certified nephrologist per 100 000 population was associated with a 1.11-fold increase in the SCR (β = 0.11; 95% confidence interval: 0.02-0.20; p = 0.022). No significant associations were observed for board-certified dialysis or apheresis specialists. These findings indicate substantial regional disparities and suggest that nephrologist distribution may influence plasmapheresis utilization in Japan.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.